The class of compounds known as RNF10 Inhibitors represents a diverse group of small molecules designed to specifically target and modulate the activity of RNF10, or RING Finger Protein 10. RNF10 is a crucial component of the ubiquitin-proteasome system, a highly regulated cellular machinery responsible for the targeted degradation of proteins. These inhibitors have been developed primarily as research tools to investigate the physiological roles of RNF10 and its substrates, shedding light on the intricate mechanisms governing protein turnover and cellular homeostasis.
Chemically, RNF10 Inhibitors exhibit a wide range of structural diversity, reflecting the multifaceted nature of RNF10's interaction with substrates and regulatory proteins. They are often designed to interfere with the enzymatic function of RNF10, disrupting its ability to attach ubiquitin molecules to specific protein targets. This ubiquitination process typically marks proteins for degradation, but RNF10 Inhibitors can block or modify this process, leading to the stabilization of RNF10 substrates. Additionally, some inhibitors function by disrupting the physical interaction between RNF10 and its target proteins, preventing their ubiquitination and subsequent degradation. The mechanism of action can also involve the inhibition of upstream components of the ubiquitin-proteasome system, indirectly affecting RNF10's function.Overall, RNF10 Inhibitors serve as valuable tools in the field of molecular biology and cellular research, enabling scientists to dissect the intricate regulatory networks involving RNF10 and its substrates. These compounds offer insights into fundamental cellular processes, such as protein degradation, signal transduction, and gene expression regulation, which are critical for understanding various physiological and pathological phenomena.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
MLN4924 inhibits RNF10 through NEDD8-activating enzyme inhibition, preventing RNF10 neddylation and subsequent activation. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 disrupts the interaction between RNF10 and p53, thereby stabilizing p53 and promoting its anti-tumor activity. | ||||||
NSC697923 | 343351-67-7 | sc-391107 sc-391107A | 1 mg 5 mg | $15.00 $52.00 | 3 | |
NSC697923 acts as an inhibitor of RNF10 by disrupting its interaction with its substrates, leading to decreased ubiquitination. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide downregulates RNF10 expression, reducing its ability to target specific proteins for ubiquitination and degradation. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 inhibits RNF10 by disrupting its binding to specific transcription factors, preventing their ubiquitination and degradation. | ||||||
PRT4165 | 31083-55-3 | sc-507487 | 10 mg | $134.00 | ||
PRT4165 inhibits RNF10-mediated ubiquitination and degradation of specific substrates involved in inflammatory responses. | ||||||
1-Benzoyl-3-phenyl-2-thiourea | 4921-82-8 | sc-258614A sc-258614 | 1 g 5 g | $43.00 $129.00 | ||
1-Benzoyl-3-phenyl-2-thiourea, also called TM-2-51, inhibits RNF10 by disrupting its interaction with specific substrates, leading to their stabilization and altered cellular function. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
PYR-41 inhibits the ubiquitin-activating enzyme E1, indirectly impacting RNF10's ability to ubiquitinate substrates. | ||||||